23/01/2012 - Press release
Doctors and researchers of Hospital del Mar and IMIM point to an acquired mutation during treatment as the causative mechanism of therapeutic failure. This discovery leads to new perspectives to improve the efficiency of treatments, the survival of patients and to advance in customized treatments against cancer
Més informació "Identified a cause of resistance to colon cancer treatment"
04/12/2011 - Press release
Nature Medicine publishes a pioneering study about a protein that regulates the expression of hundreds of genes that have a crucial role in the progression of pancreatic cancer, gliomas and possibly many other kinds of tumor. The study is directed by Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) and Raúl Méndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona).
Més informació "Discovery of a new reprogramming mechanism for tumor cells"
19/09/2011 - Press release
A team of researchers from the Hospital del Mar and IMIM, as well as from CIBER for Respiratory Diseases (CIBERES) – Carlos III Health Institute – Ministry of Science and Innovation- has lead a study proving that patients with severe COPD do not present muscular destruction until very advanced stages of the disease, especially when they still maintain a good muscle mass.
9/09/2011 - Press release
Researchers from the Hospital del Mar Oncology Department and the Cancer Research Programme of its research Institute, the ‘IMIM’, have confirmed the prognostic value of a new therapeutic target, the PARP1 protein, in breast cancer patients. This finding, which was published today in the Annals of Oncology, was achieved in partnership with the Jiménez-Díaz Foundation in Madrid and the Hospital Clínico in Valencia
21th december 2010 - Press release
Triple-negative breast cancer (Estrogen Receptor-Negative, Progesterone Receptor-Negative, and HER-Negative) is a type of breast cancer with clinical characteristics and specific pathologies that represents a relevant clinic problem, as it affects around 20% of all women with breast cancer, and especially those who are young.
15/09/2010 - Press release
A study carried out by researchers from the stem cells and cancer research group of the IMIM (Hospital del Mar Research Institute) has shown that if deactivation of the NFkB protein complex in T cell acute lymphoblastic leukaemia is forced, leukaemia is eliminated. This opens the doors for the development of new drugs for this type of leukaemia.
Més informació "New therapeutic avenue discovered to fight against leukaemia"
10 august 2010 - Press release
This is the first study in which proteins involved in metabolism and muscle contraction are shown to have higher levels of oxidation as a result of tobacco smoke, which could cause alterations in the structure and function of muscle fibres.
Més informació "Cigarette smoke contributes to muscle dysfunction"
14/07/2009 - Press release
Experts of the IMIM-Hospital del Mar Cancer Research Programme have collaborated on a study that identifies new keys in breast cancer tumour invasion. The study has been published in the prestigious journal Nature Cell Biology.
Més informació "Keys to reprogramming cells and suppressing tumour invasion"
02/04/2009 - Press release
A study has identified a new molecular mechanism connected with the proliferation and invasion of tumour cells in pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer (90% of all cases). Pancreatic cancer is one of the most lethal tumours and the fourth leading cause of cancer death worldwide.
5ht February 2009 - Press release
Although physical exercise has beneficial effects for all, even those diagnosed with Chronic Obstructive Pulmonary Disease (COPD), a new study warns that levels of oxidative stress much higher than those at rest conditions may occur in the leg muscles of patients with severe and very severe COPD. The study was carried out in collaboration with Dr. Esther Barreiro’s group at the Municipal Institute of Medical Research (IMIM-Hospital del Mar), together with Dr. Joaquim Gea, head of the Pneumology service at the Hospital del Mar and with Dr. Josep Roca, Director of the Lung Function Unit at the Hospital Clínic-IDIBAPS.
Més informació "A study questions chronic endurance exercise in patients with severe COPD"
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
